• Nem Talált Eredményt

Serum Potassium Is Associated with Cognitive Decline in Patients with Lewy Body Dementia

N/A
N/A
Protected

Academic year: 2022

Ossza meg "Serum Potassium Is Associated with Cognitive Decline in Patients with Lewy Body Dementia"

Copied!
1
0
0

Teljes szövegt

(1)

2019. 11. 30. Serum Potassium Is Associated with Cognitive Decline in Patients with Lewy Body Dementia - IOS Press

https://content.iospress.com/articles/journal-of-alzheimers-disease/jad181131 1/2

Serum Potassium Is Associated with Cognitive Decline in Patients with Lewy Body Dementia

Article type: Research Article

Authors: Giil, Lasse Melvaer (https://content.iospress.com:443/search?q=author%3A%28%22Giil, Lasse Melvaer%22%29) | Solvang, Stein-Erik Hafstad (https://content.iospress.com:443/search?

q=author%3A%28%22Solvang, Stein-Erik Hafstad%22%29) | Giil, Malin Melvaer

(https://content.iospress.com:443/search?q=author%3A%28%22Giil, Malin Melvaer%22%29) | Hellton, Kristoffer H.

(https://content.iospress.com:443/search?q=author%3A%28%22Hellton, Kristoffer H.%22%29) | Skogseth,

Ragnhild Eide (https://content.iospress.com:443/search?q=author%3A%28%22Skogseth, Ragnhild Eide%22%29) | Vik-Mo, Audun Osland (https://content.iospress.com:443/search?q=author%3A%28%22Vik-Mo, Audun Osland

%22%29) | Hortobágyi, Tibor (https://content.iospress.com:443/search?q=author%3A%28%22Hortobágyi, Tibor%22%29) | Aarsland, Dag (https://content.iospress.com:443/search?q=author%3A%28%22Aarsland,

Dag%22%29) | Nordrehaug, Jan Erik (https://content.iospress.com:443/search?q=author%3A%28%22Nordrehaug, Jan Erik%22%29)

Af liations: [a] Department of Internal Medicine, Haraldsplass Deaconess Hospital, Bergen, Norway | [b]

Institute of Clinical Sciences, University of Bergen, Norway | [c] Semmelweis University, Budapest, Hungary | [d] Norwegian Computing Center, Oslo, Norway | [e] Institute of Clinical Medicine, University of Bergen, Norway | [f] Center for Age-Related Diseases (SESAM), Stavanger University Hospital, Norway | [g]

MTA-DE Cerebrovascular and Neurodegenerative Research Group, University of Debrecen, Debrecen, Hungary | [h] Department of Old Age Psychiatry, Institute of Psychiatry, Psychology and Neuroscience, Kings College, UK

Correspondence: [*] Correspondence to: Lasse Melvaer Giil, MD, Department of Internal Medicine, Haraldsplass Deaconess Hospital, Bergen, Norway. E-mail: lassegiil@gmail.com

(mailto:lassegiil@gmail.com).

Abstract: Background:Epidemiological studies link serum potassium (K+) to cognitive performance, but whether cognitive prognosis in dementia is related to K+ levels is unknown. Objective:To determine if K+

levels predict cognitive prognosis in dementia and if this varies according to diagnosis or

neuropathological ndings. Methods:This longitudinal cohort study recruited 183 patients with mild Alzheimer’s disease or Lewy body dementia (LBD). Serum K+ and eGFR were measured at baseline and medications which could affect K+ registered. The Mini-Mental State Examination (MMSE) was measured annually over 5 years, and mortality registered. Association between K+ and √(30 -MMSE) was estimated overall, and according to diagnosis (joint model). Associations between MMSE-decline and K+ were assessed in two subgroups with neuropathological examination (linear regression) or repeated

measurements of K+ over 3 years (mixed model). Results:Serum K+ at baseline was associated with more errors on MMSE over time (Estimate 0.18, p = 0.003), more so in LBD (p = 0.048). The overall association and LBD interaction were only signi cant in the 122 patients not using K+ relevant medication. Repeated K+ measures indicated that the association with MMSE errors over time was due to a between-person effect (p < 0.05, n = 57). The association between the annual MMSE decline was stronger in patients with autopsy con rmed LBD and more α-synuclein pathology (all: p < 0.05, n = 41). Conclusion:Higher serum K+

predicts poorer cognitive prognosis in demented patients not using medications which affect K+, likely a between-person effect seen mainly in LBD.

Keywords: α-synuclein, Alzheimer’s disease, cognitive decline, kalium, Lewy body dementia, Mini-Mental State Examination, MMSE-decline, potassium, prognosis

DOI: 10.3233/JAD-181131

Journal: Journal of Alzheimer's Disease (https://content.iospress.com:443/journals/journal-of-alzheimers-disease), vol. 68, no. 1, pp. 239-253, 2019

Accepted 18 December 2018 | Published: 12 March 2019

a; b; *

a; b

c d

a; e

b; f g; h f; h

a; b

Hivatkozások

KAPCSOLÓDÓ DOKUMENTUMOK

A comparison of gray and white matter density in patients with Parkinson’s disease dementia and dementia with Lewy bodies using voxel-based mor- phometry.. Movement Disorders:

Although proprioception plays a fundamental role in motor performance and in psychological functioning, proprioceptive acuity, measured in the elbow joint, was not associated

Subjects with mild cognitive impairment (n = 12, between 58 and 95 years of age, Mean = 76.1, SD = 11.4, 50% females) based on the Petersen criteria [2] were also excluded from the

• Assuming the presence of vascular effects in cognitive decline, it was important to test the butyl analogue of scopolamine, buscopan in our phMRI model as

Mild TBI Induces Persistent Neuroinflammation and Cognitive Decline in Spontaneously Hypertensive Rats We found that expression of inflammatory cytokines IL-1β, IL-6 and TNFα

Patients were evaluated using the Hungarian version of Mini-Mental State Examination (MMSE) [42], Addenbrooke Cognitive Examination I (ACE-I) [22] and III (ACE-III),

A comparison of gray and white matter density in patients with Parkinson’s disease dementia and dementia with Lewy bodies using voxel-based mor- phometry.. Movement Disorders:

The visual hallucinations are well-formed and detailed, and frequently appear in the early stages of the disease, even before dementia becomes obvious.. Cortical and